'Mismatch repair' genetic defects drive cancer patient's response to immunotherapy drugs - News-Medical.net

'Mismatch repair' genetic defects drive cancer patient's response to immunotherapy drugs News-Medical.net Five of 20 patients (two with colon cancer, two with pancreatic cancer and one with small bowel cancer), who were listed as having progressive disease, initially responded to pembrolizumab, but their cancers often regrew in areas such as the brain or bone.

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2uPIrGt
via IFTTT